The impingement syndrome market is estimated to be valued at US$ 4.54 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The impingement syndrome market involves products utilized in the treatment of shoulder impingement syndrome. Shoulder impingement syndrome is a common orthopedic condition characterized by compression and tearing of the tendons of the rotator cuff under the acromion. Products available in the market include drugs, devices, platelet-rich plasma injections, and surgical procedures. Drugs prescribed mainly include nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce pain and inflammation. Devices used include shoulder braces and support devices to immobilize the shoulder joint.

Market Dynamics:

The impingement syndrome market is primarily driven by the increasing prevalence of shoulder impingement syndrome across the globe. According to the Orthopaedic Section of American Physical Therapy Association, shoulder impingement syndrome affects nearly 2 million people in the U.S. annually. The prevalence of shoulder impingement is also increasing due to sedentary lifestyle and increasing work-related injuries. Furthermore, growing geriatric population who are more prone to orthopedic conditions like shoulder impingement is also fueling market growth. Moreover, increasing adoption of minimally invasive surgical procedures and advancement in therapies for treatment is expected to offer lucrative growth opportunities for players in the impingement syndrome market over the forecast period.

SWOT Analysis

Strength: Impingement syndrome market has strong growth potential due to rising geriatric population globally. Increasing number of spinal surgeries and shoulder reconstruction procedures also boost the market. Availability of advanced treatment options further support market growth.

Weakness: High cost associated with shoulder reconstruction surgeries limits market growth. Lack of awareness regarding impingement syndrome in developing nations poses challenges.

Opportunity: Rising healthcare expenditures in emerging nations create lucrative opportunities. Growing adoption of minimally invasive surgeries fuels market revenue.

Threats: Risk of post-surgery complications can hamper the market. Strong competition among existing players create pricing pressure.

Key Takeaways:

The global impingement syndrome market is expected to witness high growth, exhibiting CAGR of 7.5% over the forecast period, due to increasing geriatric population globally. Rise in obese population also propels market revenue as obesity is a major risk factor for impingement syndrome.

Regional analysis:

North America dominates the global market and holds around 35% market share, due to rising healthcare spending and availability of advanced treatment facilities in the region. Asia Pacific exhibits fastest growth due rapid economic development in countries like China and India. Rising medical tourism in Asia further supplements the regional market.

Key players operating in the impingement syndrome market are Johnson & Johnson (DePuy Synthes), Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, NuVasive, Inc., Globus Medical, Inc., Wright Medical Group N.V., Arthrex, Inc., DJO Global, Inc., Össur hf., CONMED Corporation, Breg, Inc., Orthofix Medical Inc., Bioventus LLC. Key players focus on new product launches and acquisitions to strengthen their market position.

Read Our More Blogs : https://www.pressreleasebulletin.com/impingement-syndrome-market-analysis-growth-forecast-outlook-2023-2030/